Home › Kidney Cancer › NCT05218811
Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach
Recruiting
Cryotherapy and Robotic Assisted Non Ischemic Nephron Sparring Surgery
Who can join
Ages 55 to 65 · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients with ages between 45-90-year-old. * Renal tumor ≤ 7 cm in the greatest extension, \>50% exophitic. Exclusion Criteria: * Prior renal surgery * M1 Disease
About the study
Patients with renal masses eligible to partial nephrectomy often require arterial ischemia to control or prevent blood loss during this surgical procedure. This study aims to determine the safety and efficacy of renal cryoablation at the tumor bed, as a substitute measure or technique vs total or selective arterial renal ischemia.
What is being tested
- Cryoablation Assisted Partial Nephrectomy (device)
Sponsor: Urological Research Network, LLC · Participants: 150 · Started: May 15, 2020
Contact the study team
- Eusebio J Luna, MD · Phone: 3058227227
- Cielo Guerra · Phone: 3058227227
Official record on ClinicalTrials.gov — NCT05218811
Locations in the U.S.
| Florida | Urological Research Network, Miami Lakes |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.